Potential Drug Target for Neurodegenerative Diseases: IGHVIII-26-1

Target Name: IGHVIII-26-1

NCBI ID: G28347

IGHVIII-26-1

Other Name(s): IGHVIII261 | 3-26.1P | Immunoglobulin heavy variable (III)-26-1 (pseudogene) | immunoglobulin heavy variable (III)-26-1 (pseudogene)

Potential Drug Target for Neurodegenerative Diseases: IGHVIII-26-1

IGHVIII-26-1 (IGHVIII261) is a protein that is expressed in various tissues of the body, including the brain, spinal cord, and peripheral tissues. It is a member of the interleukin family of proteins, which are a group of cytokines that play a critical role in the immune response.

IGHVIII261 has been identified as a potential drug target and has been shown to play a role in several neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. Studies have shown that IGHVIII261 is involved in the regulation of several cellular processes that are important for the maintenance of brain health, including the regulation of inflammation, cell survival, and neurotransmitter signaling.

One of the key functions of IGHVIII261 is its role in the regulation of inflammation. IGHVIII261 has been shown to play a role in the regulation of the immune response, and it has been shown to interact with several immune cell types, including T cells, B cells, and macrophages. These interactions may help to protect against infection and inflammation, and may be important for the development of neurodegenerative diseases.

Another function of IGHVIII261 is its role in cell survival. IGHVIII261 has been shown to play a role in the regulation of cell survival and proliferation, and it has been shown to interact with several cell signaling pathways that are important for cell survival. These interactions may help to protect against oxidative stress and DNA damage, and may be important for the development of neurodegenerative diseases.

IGHVIII261 has also been shown to play a role in the regulation of neurotransmitter signaling. IGHVIII261 has been shown to interact with several neurotransmitter systems, including dopamine, serotonin, and GABA. These interactions may help to regulate the release and reception of neurotransmitters, and may be important for the development of neurodegenerative diseases.

In conclusion, IGHVIII-26-1 (IGHVIII261) is a protein that has been identified as a potential drug target for several neurodegenerative diseases. Its functions in the regulation of inflammation, cell survival, and neurotransmitter signaling may be important for the development of these diseases, and further research is needed to fully understand its role in these processes.

Protein Name: Immunoglobulin Heavy Variable (III)-26-1 (pseudogene)

The "IGHVIII-26-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHVIII-26-1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets